FDA warning hurts Hikma generics margins - Reuters
FDA warning hurts Hikma generics margins Reuters In February, the company received a warning letter from the US Food and Drugs Administration (FDA) about operations at its Eatontown oral dosage facility in New Jersey. Hikma said it was enhancing its processes to address the regulator's observations ...
What our clients and candidates are saying about us: Thanks a lot for all your help! I will never forget you as you not only helped me but instilled confidence in me to get my first break in this country. - Rajashree
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.